We therefore hypothesized that the NKG2A-HLA-E axis might play a crucial role in CAR-NK cell exhaustion and that knocking out the NKG2A-coding gene KLRC1 in CD33-directed CAR-NK would improve their anti-AML killing activity. The gene discussed is HLA-E; the disease is acute myeloid leukemia.